A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

Clinical trial NCT06847867 · RECRUITING

Trial details

NCT number: NCT06847867
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2025-06-05
Primary completion: 2027-07-14
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.